Federal policy is bandaging localized nursing shortages while ignoring the patient’s serious internal illness. 

The federal regulatory agency that exists to protect consumers and promote competition across the economy is newly focused on patients and clinicians as well as taxpayers.  

The U.S. Food and Drug Administration recently cleared a group of radiotherapy systems for use beyond cancer treatment. 

Advanced AI software developed by Cleerly consistently produced plaque assessments comparable to intravascular ultrasound. 

This year, imaging training programs offered a total of 1,478 positions across diagnostic and interventional radiology, a 5% increase over last year. 

When patients without diabetes land in the hospital after a heart attack or stroke, early treatment with tirzepatide may prove beneficial. 

Bringing in a new and improved cardiovascular IT system can save physicians a ton of time and lead to considerable cost savings.

Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals. 

The Cardiovascular Business Forty Under 40 Class of 2026 represents an accomplished group of clinicians, researchers, entrepreneurs and administrators who are redefining what cardiovascular leadership looks like under the age of 40. 

Imaging groups recently conveyed their concerns to Health and Human Services in a letter submitted March 16.